AJP - Regulatory, Integrative and Comparative Physiology, Vol 269, Issue 2 406-R412, Copyright © 1995 by American Physiological Society

ARTICLES

Inhibitory effect of atrial natriuretic factor on sympathetic ganglionic neurotransmission in humans

J. S. Floras
Division of Cardiology, Toronto Hospital, Ontario, Canada.

I have previously documented an inhibitory effect of atrial natriuretic factor (ANF) on postganglionic muscle sympathetic nerve activity (MSNA) in normal subjects that was consistent with either a central or ganglionic sympathoinhibitory action. To test the latter hypothesis, I examined, in seven young normotensive men, the effect of saline (as vehicle) and ANF (50 micrograms, then 50 ng.kg-1.min-1), given on 2 separate days according to a random double-blind study design, on blood pressure, heart rate, and MSNA before and after ganglionic neurotransmission was stimulated with edrophonium (ED; 12 mg iv), a rapidly reversible acetylcholinesterase inhibitor without central nervous system effects, and during subsequent augmentation of central sympathetic outflow by a cold pressor test (CPT). In five of these subjects, the protocol was replicated during nitroprusside infusion (0.4 micrograms.kg-1.min-1). ED increased MSNA during vehicle (P < 0.005) and nitroprusside (P < 0.003) but not during ANF infusion. The sympathoneural response to the combined stimuli of ED and CPT was also attenuated by ANF compared with either saline or nitroprusside infusions. Conclusions were that 1) postganglionic MSNA is increased by ED, 2) this facilitative effect of ED is attenuated by ANF, and 3) modulation of ganglionic neurotransmission is one mechanism for the relative sympatho-inhibition observed when ANF is infused at this dose.

This article has been cited by other articles:

				E. Toader, R. M. McAllen, A. Cividjian, R. L. Woods, and L. Quintin Effect of systemic B-type natriuretic peptide on cardiac vagal motoneuron activity Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3465 - H3470. [Abstract] [Full Text] [PDF]

				L. M. Hunt, E. W. Hogeland, M. K. Henry, and S. J. Swoap Hypotension and bradycardia during caloric restriction in mice are independent of salt balance and do not require ANP receptor Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1446 - H1451. [Abstract] [Full Text] [PDF]

				L. G. MELO, M. E. STEINHELPER, S. C. PANG, Y. TSE, and U. ACKERMANN ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models Physiol Genomics, June 29, 2000; 3(1): 45 - 58. [Abstract] [Full Text] [PDF]

				R. D. Deliva and U. Ackermann Atrial natriuretic peptide and mechanisms of cardiovascular control. Role of serotonergic receptors Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R711 - R717. [Abstract] [Full Text] [PDF]

				S.-i. Ando, M. A. Rahman, G. C. Butler, B. L. Senn, and J. S. Floras Comparison of Candoxatril and Atrial Natriuretic Factor in Healthy Men : Effects on Hemodynamics, Sympathetic Activity, Heart Rate Variability, and Endothelin Hypertension, December 1, 1995; 26(6): 1160 - 1166. [Abstract] [Full Text]

				J. Cui, T. E. Wilson, and C. G. Crandall Baroreflex modulation of muscle sympathetic nerve activity during cold pressor test in humans Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1717 - H1723. [Abstract] [Full Text] [PDF]